Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q4 2024 Earnings

30OctConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.37

-0.33

-0.28

-0.24

Details

Expected EPS

-0.374716

Actual EPS

-0.24

Surprise EPS

0.13

Surprise Percent

+35.95%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.24 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.